Methyl 2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate, 95.0%, 5g

1-Fluoro-2,4-dimethylbenzene, 95.0%, 25g

2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 97.0%, 5g

5-chloro-1-(3-fluoro-4-methylphenyl)-1-oxopentane, 97.0%, 2g

1-Cyclopentene-1-carbaldehyde, 95.0%, 250mg

Thioacetanilide>98.0%(N)5g

1-Bromo-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine hydrochloride, 97+%, 250mg

(S)-2-(((Benzyloxy)carbonyl)amino)-3-cyclohexylpropanoic acid, 95.0%, 25g

N'-[1-Amino-2-(3-(trifluoromethyl)phenoxy)ethylidene]hydrazinecarboxylic acid tert-butylester, 95.0%, 500mg

3,6-Dichloro-4,5-dimethylpyridazine, 95.0%, 5g

TASQUINIMOD, 95%, 250mg

6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl piperazine-1-carboxylate hydrochloride, 99%, 250mg

1-(4-Chlorophenyl)cyclopropane carbonitrile, 95.0%, 1g